Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06874595 · ClinicalTrials.gov registry record · NA

Psychobiological Responses Following Exercise and Brain Stimulation

A NA study of Psychological, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT06874595: Recruiting NA study of Psychological, sponsored by Virginia Commonwealth University.

NCT06874595 is a NA study of Psychological that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 29 participants, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06874595, a NA study of Psychological, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

Anxiety disorders are the most common mental health diagnosis in the US; 19.1% of U.S. adults (23.4% for females and 14.3% for males). In addition, the Global Burden of Disease study (2010) found that anxiety disorders were the sixth leading cause of disability (years of life lived with disability). These debilitating disorders are characterized by excessive worry and fear about everyday situations, and physical symptoms including restlessness, being easily fatigued, difficulty concentrating, irritability, muscle tension, or sleep disturbance. Furthermore, anxiety is linked to other mental disorders including depression and substance abuse; is associated with cardiovascular disease risk factors and a higher rate of cardiovascular disease; and is related to premature mortality. These data have led to the investigation of a breadth of plausible treatments for anxiety, including medications and psychotherapy. However, likely due to the breadth of complex mechanisms involved in the pathophysiology of anxiety disorders and the unfavorable side effects of various medications, a considerable number of individuals do not have a satisfactory response to these treatments. This has led investigators to examine plausible novel interventions to alleviate anxiety and its symptoms.

Primary Outcome

Physical activity prior to HD-tDCS will enhance the anxiolytic effects beyond the benefits of physical activity alone and HD-tDCS alone. Thus, demonstrating a priming effect of PA on the anxiety alleviating electrical pathways that HD-tDCS activates at subthreshold level. Visual Analog Scale for Anxiety (VAS-Anxiety; rating from 0 = "not at all anxious" to 100 = "the most anxious I have ever felt") and three other scales assessing tingling, stiffness and numbness will be administered with a simi

Conditions Studied

Interventions

  • OTHER Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS)
  • OTHER Cycling exercise at 65% of HRR exercise followed by sham HD-tDCS (exercise + sham tDCS)
  • OTHER No exercise followed by HD-tDCS (no exercise + HD-tDCS).
  • OTHER State Anxiety Inventory
  • OTHER Visual Analog Scale for Anxiety

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2025-03-19
Est. Completion 2027-02
Phase NA
Virginia Commonwealth University

558 total trials

What NCT06874595 shows while recruiting

NCT06874595 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Psychological appearing as the primary indexed condition, and to 5 interventions - of which Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS) is the first listed.

NCT06874595 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06874595 about?

NCT06874595 is a clinical study titled "Psychobiological Responses Following Exercise and Brain Stimulation". Anxiety disorders are the most common mental health diagnosis in the US; 19.1% of U.S. adults (23.4% for females and 14.3% for males). In addition, the Global Burden of Disease study (2010) found that anxiety disorders were the sixth leading cause of disability (years of life lived with disability)....

What is the current status of trial NCT06874595?

This trial is currently recruiting. It is a NA study. The enrollment target is 29 participants. The study started on 2025-03-19. Estimated completion is 2027-02.

What conditions does trial NCT06874595 study?

This clinical trial studies the following conditions: Psychological.

What interventions are being tested in trial NCT06874595?

The interventions under investigation include: Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS) (OTHER), Cycling exercise at 65% of HRR exercise followed by sham HD-tDCS (exercise + sham tDCS) (OTHER), No exercise followed by HD-tDCS (no exercise + HD-tDCS). (OTHER), State Anxiety Inventory (OTHER), Visual Analog Scale for Anxiety (OTHER).

Who is sponsoring clinical trial NCT06874595?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06874595 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06874595's enrollment target sits among peer trials

29 9th of 9 higher than 1 of 9 other Psychological trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06874595, the US trial registry maintained by the National Library of Medicine. NCT06874595 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.